FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Propofol Injectable Emulsion
Status: Currently in Shortage
»Date first posted: 04/10/2020
»Therapeutic Categories: Anesthesia

Expand all

Dr. Reddy's Laboratories, Inc. (Revised 03/29/2021)

Company Contact Information:
866-732-3952

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200mg/20mL 10ct (NDC 43598-265-58) Pack size discontinued
200mg/20mL vial, individual (NDC 43598-265-20) No current supply Partial shipments on allocation April-July 2021

Extended Use Dates To Assist with Drug Shortages

Demand increase for the drug
500mg/50mL 20ct (NDC 43598-548-21) No current supply Partial shipments on allocation April-July 2021 Demand increase for the drug
500mg/50mL vial, individual (NDC 43598-548-50) No current supply Partial shipments on allocation April-July 2021

Extended Use Dates To Assist with Drug Shortages

Demand increase for the drug
1000mg/100mL vial, 10ct (NDC 43598-549-10) No current supply Partial shipments on allocation April-July 2021 Demand increase for the drug
1000mg/100mL vial, individual (NDC 43598-549-52) No current supply Partial shipments on allocation April-July 2021

Extended Use Dates To Assist with Drug Shortages

Demand increase for the drug
200mg/20mL vial, 25ct (NDC 43598-265-25) No current supply Partial shipments on allocation April-July 2021 Demand increase for the drug

Fresenius Kabi USA, LLC (Revised 03/15/2021)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg per 10 mL (10 mg per mL), single patient use only, 10 mL (NDC 63323-269-10) Available Check wholesaler inventory
200 mg per 20 mL (10 mg per mL), single patient use only, 20 mL (NDC 63323-269-29) Available Check wholesaler inventory Demand increase for the drug
500 mg per 50 mL (10 mg per mL), single patient use only, 50 mL (NDC 63323-269-50) Allocating to wholesalers / Check wholesaler inventory COVID-19 demand Demand increase for the drug
1000 mg per 100 mL (10 mg per mL), single patient use only, 100 mL (NDC 63323-269-65) Allocating to wholesalers / Check wholesaler inventory COVID-19 demand Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 04/08/2021)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg/mL, 20 mL vial (NDC 0641-6194-10) This presentation is temporarily on backorder. Additional lots will be scheduled for manufacturing in the April - May 2021. Product will be made available as it is released. Demand increase for the drug
10 mg/mL, 50 mL vial (NDC 0641-6195-20 This presentation is temporarily on backorder. Additional lots will be scheduled for manufacturing. Product will be made available as it is released. Demand increase for the drug
10 mg/mL, 100 mL vial (NDC 0641-6196-10 This presentation is temporarily on backorder. Additional lots will be scheduled for manufacturing. Product will be made available as it is released. Demand increase for the drug

Hospira, Inc. (Revised 04/08/2021)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mg/20 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-30) Limited Supply Available. Next Delivery: May 2021; Estimated Recovery: June 2021 Demand increase for the drug
500 mg/50 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-33) Next Delivery: July 2021; Estimated Recovery: August 2021 Demand increase for the drug
1000 mg/100 mL (10 mg/mL) Single Dose/Single Patient Use Glass Fliptop Vial (NDC 00409-4699-24) Limited Supply Available. Next Delivery: April 2021; Estimated Recovery: June 2021 Demand increase for the drug

Sagent Pharmaceuticals (Revised 03/25/2021)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200mg per 20ml (NDC 25021-608-20) Available. On Allocation Demand increase due to Covid-19
500mg per 50ml (NDC 250-21-608-50) Available
1000mg per 100ml (NDC 25021-608-51) Available

Teva Pharmaceuticals (Reverified 03/30/2021)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10MG/ML 10X100ML VL (NDC 0591-2136-68) Limited supply available. Next Delivery and Estimated Recovery: TBD Supply chain has been impacted by shipping delays due to COVID-19

Link to FDA's List of Extended Use Dates

Other
10MG/ML 20X50ML VL (NDC 0591-2136-51) Limited supply available. Next Delivery and Estimated Recovery: TBD Supply chain has been impacted by shipping delays due to COVID-19

Link to FDA's List of Extended Use Dates

Other
10MG/ML 25X20ML VL (NDC 0591-2136-95) Limited supply available. Next Delivery and Estimated Recovery: TBD Supply chain has been impacted by shipping delays due to COVID-19

Link to FDA's List of Extended Use Dates

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English